Your session is about to expire
← Back to Search
Peer Support Intervention for COVID-19 Related Mental Health Issues (RIWP+ Trial)
RIWP+ Trial Summary
This trial will test a peer support intervention to help Latinx and Black immigrants and refugees cope with mental health, financial, and stress-related problems caused by the COVID-19 pandemic.
RIWP+ Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRIWP+ Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RIWP+ Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a Latinx immigrant or African refugee over 18 living in New Mexico.I do not have severe mental health issues that prevent me from joining group activities.
- Group 1: Treatment-as-usual Waitlist Control Group
- Group 2: Refugee & Immigrant Well-being Project (RIWP) Intervention
- Group 3: Random Sample of Latinx Immigrants
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the Refugee and Immigrant Well-being Project (RIWP) have the FDA's blessing?
"The Refugee and Immigrant Well-being Project (RIWP) is considered safe by our team, who gave it a score of 3. This is because it is a Phase 3 trial, meaning that not only is there some evidence of its efficacy, but that there have also been multiple rounds of testing affirming its safety."
How many people are the researchers hoping to enroll in this trial?
"Yes, this trial is still recruiting patients according to the most recent information from clinicaltrials.gov. The posting date was October 18th 2021 and the last edit was on May 25th 2022. They are looking for 1200 patients from 1 site."
Share this study with friends
Copy Link
Messenger